Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma.

ABSTRACT:

SUBMITTER: Shah N 

PROVIDER: S-EPMC4785590 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature